Trazadone is an antidepressant in which belongs to Serotonin Antagonist and Reuptake Inhibitor (SARI) class. Selective Serotonin Reuptake Inhibitors (SSRIs) are common treatments for patients suffering from Major Depressive Disorder (MDD). The new study indicates that Trazadone has less adverse effects than some other SSRIs such as Sertraline and fluoxetine. Major Depressive Disorders (MDD) also known as clinical depression has been one of the most common mental disorder than results in a persistent low mood, low self-esteem and lack of interest or pleasure.
The common treatment of MDD has been medication with SSRIs after thorough psychological and psychiatric assessment. Along with behavioral therapy and psychotherapy, antidepressants play a major role in the management of MDD. Some studies in the past have suggested that SSRIs are associated with adverse effects on sexual function.…
